Novel Therapeutic Approaches to Tuberculosis
Organizer(s): Christopher M. Sassetti and Thomas G. EvansDate: March 30 - April 04, 2014
Location: Keystone Resort, Keystone, CO, USA
Despite more than a century of research, tuberculosis kills millions every year. The reasons we are unable to control this disease are well documented; the lack of an effective vaccine, inefficient chemotherapy, and an inability to predict who is at risk of disease. Traditional approaches to antibacterial and vaccine development have produced only incremental improvements in TB therapy, and have had little effect on transmission in the developing world. This symposium will explore novel strategies to treat this disease, either through direct antimicrobial interventions or the manipulation of host immunity. The sessions will explore three topical areas: • The mechanisms underlying the inflammatory response to M. tuberculosis, and novel strategies to ameliorate disease through the manipulation of this response. • New approaches to accelerate TB chemotherapy, concentrating on genetic/chemical synergies, specific targeting of persistent bacterial populations, and host-directed antimicrobial therapies. • Immunotherapy for both latent and active disease, with an emphasis on cytokine modulation and therapeutic vaccines. This symposium will assemble a diverse group of scientists specializing in immunology, bacteriology, cell biology, and therapeutic development. To ensure that insights from basic science are discussed in the context of practical therapeutic solutions, attendees will be drawn from both academic and industrial institutions. A particular emphasis will be placed on lessons gleaned from other systems, such as cancer, acute inflammation, and viral infections, which could be applied to tuberculosis. This diversity of background and approach will encourage the development of truly novel approaches to treat this devastating disease.
Global Health Travel Award Deadline: October 29 2013
Scholarship Deadline: December 3 2013
Discounted Abstract Deadline: December 3 2013
Abstract Deadline: January 7 2014
Discounted Registration Deadline: January 29 2014
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
We gratefully acknowledge the generous grant for this conference provided by:National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13AI109839-01
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.